Relay Therapeutics, Inc. (RLAY)
17.30
+0.24
(+1.41%)
USD |
NASDAQ |
Oct 15, 16:00
17.30
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Cash from Operations (TTM) : -212.20M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -212.20M |
| March 31, 2026 | -213.36M |
| December 31, 2025 | -235.46M |
| September 30, 2025 | -248.46M |
| June 30, 2025 | -261.42M |
| March 31, 2025 | -271.99M |
| December 31, 2024 | -249.11M |
| September 30, 2024 | -280.43M |
| June 30, 2024 | -280.74M |
| March 31, 2024 | -283.51M |
| December 31, 2023 | -300.32M |
| September 30, 2023 | -268.21M |
| June 30, 2023 | -258.96M |
| March 31, 2023 | -247.45M |
| Date | Value |
|---|---|
| December 31, 2022 | -229.49M |
| September 30, 2022 | -212.12M |
| June 30, 2022 | -199.17M |
| March 31, 2022 | -170.22M |
| December 31, 2021 | -74.41M |
| September 30, 2021 | -69.97M |
| June 30, 2021 | -40.81M |
| March 31, 2021 | -33.52M |
| December 31, 2020 | -102.49M |
| September 30, 2020 | -89.98M |
| June 30, 2020 | -83.44M |
| March 31, 2020 | -77.65M |
| December 31, 2019 | -66.13M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.42M |
| TG Therapeutics, Inc. | 17.88M |
| Karyopharm Therapeutics, Inc. | -65.35M |
| Spyre Therapeutics, Inc. | -209.47M |
| Akebia Therapeutics, Inc. | 41.55M |